Skip to content
Open Data Finder
Open Government Canada

Post-Notice of Compliance (NOC) Changes – Quality Guidance

Published by Health Canada | Santé Canada

About this dataset

This guidance document applies to sponsors intending to make changes to new drugs that have received a NOC pursuant to Section C.08.004 of the Food and Drug Regulations. This may include pharmaceuticals, biologics and radiopharmaceuticals for human use and pharmaceutical, radiopharmaceutical and certain biotechnological products for veterinary use.

Post-Notice of Compliance (NOC) Changes – Quality Guidance · Open Data Finder